41 results
8-K
EX-10.3
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.1
fffwgc 1x495wqt87
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.2
969pr kb9vn1kms5dqes
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.1
zi19c10gkvjmqsc4b1
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.3
4a15adc97x b9zma
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.1
4frtq z4r1w73384
1 Sep 22
Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors
5:30pm
8-K
EX-10.1
ss1j7z4ru0ln
16 May 22
Entry into a Material Definitive Agreement
9:49pm
8-K
EX-10.2
y32fqhnfgiznrncs9k
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
8-K
EX-10.1
ww0azh alwre
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
8-K
EX-10.3
99o28mymrqtq5h1us0vg
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
S-1
EX-10.9
hmhbcp3skt
23 Jul 20
IPO registration
12:28pm